Michael H. Davidson
Michael H. Davidson has made 1 open-market purchase worth $227k since Sep 15, 2026, in 1 company. The latest: $227k of NAMS, filed Sep 15, 2026, scored 36 out of 100.
CEO, NewAmsterdam Pharma Co N.V.
Follow Michael H. Davidson, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Sep 15 Form 4 (opens sec.gov) |
NAMSNewAmsterdam Pharma Co N.V. · CEOCEO · Near 52-week low | +1% stake | 36 | $227k 10,000 at $22.65 |
+7.1% | −6.4% |
Track record (hypothetical): a week after the filing, these buys averaged +7.1% (100% up, 1 measured); a month after, −6.4% (0% up, 1 measured).
Questions
What stock has Michael H. Davidson bought?
NAMS (NewAmsterdam Pharma Co N.V.), all on the open market and reported on SEC Form 4.
When did Michael H. Davidson last buy?
Sep 15, 2026: 10,000 shares of NAMS at $22.65, $227k in all (Form 4 (opens sec.gov)).
Has Michael H. Davidson filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Michael H. Davidson a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Sep 15, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer